If made official, the proposed rule would give Part D and Medicaid beneficiaries expanded coverage to antiobesity drugs ...
The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.
1hon MSNOpinion
Congress has been considering bipartisan solutions to help address the growing obesity problem for over a decade now.
The plans from the Department of Health and Human Services come on the heels of criticism Ozempic and other weight loss medications received by RFK Jr.
A row is brewing between the White House and Robert F Kennedy Jr after the Biden administration proposed making millions of ...
The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and $11 billion for Medicaid over a decade. Total Medicare drug spending over ...
The Biden administration on Tuesday proposed expanding drug coverage under Medicare and Medicaid to include anti-obesity ...
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
The Biden administration is reinterpreting federal law to allow Medicare and Medicaid patients access to anti-obesity ...
Whether this proposed rule actually has any impact remains to be seen, especially with a new administration led by Donald ...
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound c ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback